ROC curves indicated that TPX2 had moderate predictive power for 1-, 3-, and 5-year survival of patients with HCC, with areas under the curve of 0.73, 0.668, and 0.654, respectively. The gene discussed is TPX2; the disease is hepatocellular carcinoma.